Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

VRAX Virax Biolabs Group Ltd

0,8395

0,0559 (7,13%)

17 Mai 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Virax Biolabs (NASDAQ:VRAX)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Virax Biolabs Charts.

Virax Biolabs (NASDAQ:VRAX)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Virax Biolabs Charts.

News Virax Biolabs Group Ltd

Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024
Donnerstag 25 April 2024 (3 Wochen vor) • PR Newswire (US)

Virax Biolabs to Participate at ESCMID Global 2024
Dienstag 16 April 2024 (1 Monat vor) • PR Newswire (US)

Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency
Freitag 15 März 2024 (2 Monate vor) • PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Montag 22 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Montag 22 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Freitag 12 Januar 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Donnerstag 21 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients
Donnerstag 21 Dezember 2023 (5 Monate vor) • PR Newswire (US)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Mittwoch 20 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mittwoch 20 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Mittwoch 20 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Montag 18 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Weitere Virax Biolabs Group Ltd News-Artikel

Token Prometeus Network

Golden Cariboo Resources (PK)

Invesco S&P SmallCap Mom...

Direxion Daily Technolog...

Blue Star Opportunities (PK)

PIMCO Municipal Income

UVA Unconstrained Medium...

Grange Resources (PK)

Eternal Rock Token

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen